Markets Hunter - With Hunter Gaylor

JOHN SILSETHCEO John has over 25 years of senior management experience in the design, manufacturing, and marketing of high- performance vehicles. John was the founder and CEO of Viper Motorcycle Company and served in several roles at Norton Motorcycles, including President. The Riley branded Streetfighter aims to capture a niche powersports market with race-worthy performance integrated with the advantages of leading electrification technology. REV Technologies, (www.rileyev.com) announced it has entered into a definitive agreement with Riley Technologies to provide design, technical development, production, and marketing support for an all-electric performance vehicle, the “Riley Streetfighter.” The Streetfighter will be available in customizable E-propulsion system and bodywork configurations, including the availability of a 530 HP E Propulsion system wrapped in Carbon Fiber Bodywork with a total vehicle weight under 2000 lbs. REV President John Silseth stated, “REV Technologies was formed to develop and market electric performance vehicles under the Riley brand. Our mission is to develop race to road electrification performance technology as the increasing role of electric propulsion in the automotive industry undergoes a massive technology disruption.” ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

Cyber Security should be at the top of a company list of must haves.

What is BRICS and what does the future like for them. BRICS countries have been striving to balance global development in the interests of developing there economies. We will cover Why this matters.

This is QFS intro is part of an on going financial series covering cyber, crypto and Quantum. What will our future look like with this system.

A quick weekend headline reading going over a few thoughts on the market and some interesting events.

In this Market Insight we will discuss a quick overview of the Business Jet Market in 2021 and beyond. 

In this Market Insight, we discuss a brief overview of what the future has in store for the Air Cargo Market. 

In this special topic based, four-part miniseries, we are discussing a very important and timely conversation around God & Government. In today's society the name of Jesus is seems to be more controversial than any government or political figure in the world. How can we be Indivisible & Unbreakable? This is the question? Don't forget to like and share as we have a "straight talk" conversation around God & Government.

In this special topic based, four-part miniseries, we are discussing a very important and timely conversation around God & Government. In today's society the name of Jesus is seems to be more controversial than any government or political figure in the world. Are We Really Under God? This is the question? Don't forget to like and share as we have a "straight talk" conversation around God & Government.

In this special topic based, four-part miniseries, we are discussing a very important and timely conversation around God & Government. In today's society the name of Jesus is seems to be more controversial than any government or political figure in the world.  What Does it means to be Ambassadors? This is the question? Don't forget to like and share as we have a "straight talk" conversation around God & Government.

In this special topic based, four-part miniseries, we are discussing a very important and timely conversation around God & Government. In today's society the name of Jesus is seems to be more controversial than any government or political figure in the world. Are we truly "One Nation Under God" is the question? Don't forget to like and share as we have a "straight talk" conversation around God & Government.

We embark on a transformative journey into the heart of the health and wellness revolution with TransGlobal Assets Inc., symbol TMSH, leading the charge in diversified investments. Join us for an exclusive interview with the visionary CEO, Ilya Strashan, as we delve into the intricacies of one of their flagship subsidiaries, Better Health Sciences, Inc. 🚀 Revolutionizing Health and Wellness: Better Health Sciences, Inc. is not just a company; it's a force driving change in the health and wellness industries. With a steadfast commitment to staying at the forefront, Better Health Sciences specializes in developing cutting-edge technologies and solutions that redefine industry standards. CEO Ilya Strashan guides us through their mission to positively impact lives and contribute to the exponential growth of these vital sectors. 🌱 Cutting-Edge Technologies for a Better Tomorrow: In this in-depth interview, discover the latest advancements pioneered by Better Health Sciences. From groundbreaking products to innovative services, explore how their focus on technology is shaping the future of wellness. Ilya Strashan provides exclusive insights into the company's relentless pursuit of excellence and its dedication to enhancing the well-being of individuals worldwide. 🎙️ Exclusive CEO Perspective: Gain firsthand knowledge from CEO Ilya Strashan as he shares his vision for Better Health Sciences and TransGlobal Assets Inc. Learn about the strategies, values, and long-term goals that guide the company's decisions. This interview offers a rare glimpse into the mind of a leader driving positive change at the intersection of business and wellness. 📈 TransGlobal Assets Inc.: A Holistic Approach to Holdings: Beyond Better Health Sciences, understand how TransGlobal Assets Inc. strategically navigates the world of business holdings. Ilya Strashan discusses the company's diversified investment approach, positioning TransGlobal Assets as a key player in shaping the landscape of progressive, forward-thinking businesses. 🌟 A Gateway to the Future: Elevate your understanding of the health and wellness sectors as we explore the dynamic intersection of business, health, and technology. This interview is your gateway to the future of wellness, offering valuable insights for professionals, enthusiasts, and anyone passionate about the transformative power of innovation. 🔍 Stay Ahead of the Curve: Join us for this enlightening conversation that transcends industries. Stay ahead of the curve with TransGlobal Assets Inc.'s commitment to innovation and progress. Don't miss this exclusive interview; your journey towards a healthier and more advanced future starts here! https://betterhealthsciences.ca#TransGlobalAssets #BetterHealthSciences #WellnessInnovation #BusinessHoldings #HealthTechRevolution #CEOInterview #IndustryInnovations #FutureofWellness #CuttingEdgeTechnologies #PositiveImpact

The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. https://www.petvivo.com/news-1/petviv... “Our biocompatible particulate technology and the claims to be issued in this patent application provides extremely comprehensive coverage. This patent increases the scope of our patent claims thereby expanding our competitive advantage in the commercialization of products used in the treatment of humans and companion animals,” stated PetVivo Chief Executive Officer, John Lai. https://www.petvivo.com/abouthttps://... https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. https://www.petvivo.com/news-1/petviv... “Our biocompatible particulate technology and the claims to be issued in this patent application provides extremely comprehensive coverage. This patent increases the scope of our patent claims thereby expanding our competitive advantage in the commercialization of products used in the treatment of humans and companion animals,” stated PetVivo Chief Executive Officer, John Lai. https://www.petvivo.com/abouthttps://twitter.com/petvivo https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. https://www.petvivo.com/news-1/petviv... “Our biocompatible particulate technology and the claims to be issued in this patent application provides extremely comprehensive coverage. This patent increases the scope of our patent claims thereby expanding our competitive advantage in the commercialization of products used in the treatment of humans and companion animals,” stated PetVivo Chief Executive Officer, John Lai. https://www.petvivo.com/abouthttps://twitter.com/petvivo https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

The Company’s first product that implemented the Biomatrix Particulate Technology, SPRYNG™ with OsteoCushion™ Technology, is an intra-articular injectable veterinary medical device consisting of sterilized, extra-cellular matrix microparticles; SPRYNG microparticles perform in the joint as wet, slippery micro-cushions used in the management of lameness and other joint related afflictions, such as osteoarthritis. “As a result of our successes demonstrated by administering SPRYNG in a large number of companion animals and horses, we are highly encouraged by the prospect of enhancing the lives of people suffering from a variety of medical afflictions, such as osteoarthritis,” said John Lai PetVivo’s Chief Executive Officer. “We are looking forward to moving one or more products through the regulatory process as quickly as possible so that we can begin commercialization in a number of very large market sectors.” https://www.petvivo.com/about https://twitter.com/petvivo https://www.petvivocares.org/ ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

Hunter Gaylor is Joined by Quantum Computing, Inc. (NASDAQ: QUBT) ($QUBT) Interviews Robert Liscouski, President, CEO, and Chairman. Join me as I have an in-depth discussion with Robert Live from the heart of the Big Apple to discuss the role Quantum Computing will play in helping solve some on our nations greatest challenges. Robert Liscouski has served as president, CEO, and chairman of QCI since February 2018, bringing to the company more than 35 years of executive experience at public and private companies, and federal agencies. He has extensive experience developing critical programs for protecting national security interests and essential infrastructure, as well as in crisis management, organizational development, and strategic planning. Robert’s public sector experience includes time in the U.S. Department of Homeland Security, the U.S. Department of State, the Bergen County Prosecutor's Office, and served on the Intelligence ScienceBoard supporting the CIA and NIA. On the private sector side, Robert held roles at Implant Sciences, Coca-Cola Company, and Orion Scientific Systems. Robert currently serves on the board of technical advisors for the National Center for Missing and Exploited Children and the board of the National Child Protection Task Force. He received his Bachelor of Science from John Jay College of Criminal Justice and Master of Public Administration from the John F. Kennedy School of Government, Harvard University. You can learn more about $QUBT and their company Here. https://www.quantumcomputinginc.com/ Spotify: https://open.spotify.com/episode/5ngQ... Twitter: https://twitter.com/HunterGaylorhttps... S StockTwits: https://stocktwits.com/HunterGaylor ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

Dais offers “industry-changing” nanotechnology applications that address the growth of global water and energy demand. Furthering Dais’ proven ability to create eco-friendly heating and cooling products, the company is now innovating cost-effective and energy-efficient methods for both water purification and energy storage solutions. Recently named one of the “12 Energy Projects to Watch in 2012”, Dais will continue to deploy its nanotechnology plastic materials into the 21st century and beyond. Air. Energy. Water. Moving Molecules for a Sustainable Future. Follow https://twitter.com/DaisAnalytic ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

Join me as I speak a veterinary biotech and biomedical device company primarily engaged in the business of translating or adapting human biotech and medical technology into products for commercial sale in the veterinary market to help companion animals such as dogs and horses suffering from arthritis and other afflictions. $PETV Website:https://www.petvivo.com/about https://twitter.com/petvivo ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.

Join me as I speak with Joe Salvani about $QUBT “The market for a low-cost ability to objectively analyze individual personalities en mass is an extremely large and lucrative market. In the quantum space, QCI has established itself as a leader in hardware innovation and commercialization. Like QCI, millionways has already begun commercialization. As of last summer, we have conducted preliminary integration of use cases with over 50 major US companies. Also, like QCI, we have a core technology that can be easily and affordably flexed to solve major business challenges in any industry, which makes the idea of combining our two teams even more attractive. Within the first few days of our launching our testing engagement in April, it became apparent that using QCI’s unique hybrid systems of quantum, photonics, and electronics would allow our AI developers the ability to extend our already vast capabilities using the massive increase in processing power with amazingly low electricity costs. Even more impressive, given the predictive and virtually simultaneous processing capability of QCI in all matters of rich media, future applications of our combined technology could be endless.”For more information, visit https://www.quantumcomputinginc.com/Spotify: https://open.spotify.com/episode/5ngQ...Twitter: https://twitter.com/HunterGaylorhttps... StockTwits: https://stocktwits.com/HunterGaylor ****** The views expressed in Markets Hunter's content, productions, or other investor relations materials and presentations may be subject to change. Neither Markets Hunter nor any of its data or content providers shall be held responsible for any errors or delays in the content, or for any actions taken based on the information provided. All data and information is intended to be used for informational or entertainment purposes only. On occasion, we enter into contracts with third parties or publicly traded companies and receive financial remuneration in exchange for disseminating information and opinions regarding the company and the stock market such as this video. Markets Hunter is not a licensed broker-dealer or registered investment advisor. The content and productions of Markets Hunter are sourced from reliable data sources, though accuracy and completeness are not guaranteed. Consequently, the information should not be seen as tailored advice to any individual investor's specific needs. Markets Hunter.com is devoted to furnishing our readers with beneficial insights into publicly traded companies.